glucagon-like peptide 2-(3-33)



glucagon-like peptide 2-(3-33)

D1DD1G2GG2S3SS3F4FF4S5SS5D6DD6E7EE7M8MM8N9NN9T10TT10I11II11L12LL12D13DD13N14NN14L15LL15A16AA16A17AA17R18RR18D19DD19F20FF20I21II21N22NN22W23WW23L24LL24I25II25Q26QQ26T27TT27K28KK28I29II29T30TT30D31DD31

SMILES None
InChIKey MYKFSDGCGNRIEA-KXTJMAPWSA-N
Sequence DGSFSDEMNTILDNLAARDFINWLIQTKITD

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)


No bioactivity data available.

glucagon-like peptide 2-(3-33)

D1DD1G2GG2S3SS3F4FF4S5SS5D6DD6E7EE7M8MM8N9NN9T10TT10I11II11L12LL12D13DD13N14NN14L15LL15A16AA16A17AA17R18RR18D19DD19F20FF20I21II21N22NN22W23WW23L24LL24I25II25Q26QQ26T27TT27K28KK28I29II29T30TT30D31DD31

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0


Compound is not listed as a drug.